Skip to Content


Active Substance: imiquimod
Common Name: imiquimod
ATC Code: L03AX
Marketing Authorisation Holder: Laboratoires 3M Santé
Active Substance: imiquimod
Status: Withdrawn
Authorisation Date: 1998-09-18
Therapeutic Area: Condylomata Acuminata
Pharmacotherapeutic Group: Immunostimulants

Therapeutic Indication

Imiquimod cream is indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients.

The marketing authorisation for Zartra has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.